Houlihan Lokey Advises Element Materials Technology

Houlihan Lokey is pleased to announce that Element Materials Technology (Element) has reached an agreement to sell its Life Sciences Testing Services business in North America to Eurofins Scientific SE (Eurofins; EUFI.PA) for an enterprise value of $400 million. The transaction is subject to customary conditions, including regulatory approvals, and is expected to close in Q4 2026. Houlihan Lokey is serving as the exclusive financial advisor to Element.

Element’s North America Life Sciences Testing Services includes a range of Biopharma product testing, Environmental testing and Food testing services, offered by a network of 27 laboratories and facilities. It employs approximately 750 full-time employees and is expected to generate annual revenues of more than $150 million in 2026.

This addition to Eurofins’ BioPharma and Life businesses in North America will expand the geographic presence of Eurofins’ laboratory network into certain key regions of the United States and Canada, where Eurofins has historically been underrepresented. The acquired operations will benefit from access to the breadth of customer offerings and the economies of scale of Eurofins’ established hub-and-spoke laboratory networks. The transaction aligns with Eurofins’ ongoing focus on allocating capital to its core testing-for-life capabilities.

About Eurofins Scientific

Eurofins is “Testing for Life”. The Eurofins Scientific SE network of independent companies believes that it is a global leader in food, environment, pharmaceutical, and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences, and agroscience contract research services. It is one of the market leaders in certain testing and laboratory services for genomics, support for clinical studies, and in biopharma contract development and manufacturing. Eurofins also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in vitro diagnostic products.

With over 65,000 staff across a decentralised and entrepreneurial network of more than 950 laboratories in over 1,000 companies in 59 countries, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of a wide range of products, as well as providing innovative clinical diagnostic testing services and in vitro diagnostic products.

Eurofins companies’ broad range of services are important for the health and safety of people and our planet. The ongoing investment to become fully digital and maintain the best network of state-of-the-art laboratories and equipment supports its objective to provide its customers with high-quality services, innovative solutions, and accurate results in the best possible turnaround time (TAT). Eurofins companies are well positioned to support clients’ increasingly stringent quality and safety standards and the increasing demands of regulatory authorities, as well as the evolving requirements of healthcare practitioners around the world.

About Element Materials Technology

Element is one of the world’s leading providers of laboratory-based testing services. It supports more than 50,000 customers operating in some of the world’s most technical and highly regulated industries, where failure in the use of their products, materials, and technologies is not an option. Headquartered in London, Element’s more than 8,500 scientists, engineers, and technologists work across a global network of more than 270 laboratories and support customers from early R&D, through complex regulatory approvals, and into production, ensuring their products are safe and sustainable and achieve market access.

Houlihan Lokey is serving as the exclusive financial advisor to Element in a deal that exemplifies the continued success of Houlihan Lokey’s dedicated global coverage of the TICC sector.

RELATED: Business Services, Mergers and Acquisitions